SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-021528
Filing Date
2004-02-12
Accepted
2004-02-12 17:26:35
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR CORTEX PHARMACEUTICALS d10q.htm 10-Q 224063
3 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION FILED 12/15/03 dex33.htm EX-3.3 9020
4 LICENSE AGREEMENT DATED 06/25/93, AS AMENDED 05/28/03 dex1031.htm EX-10.31 152954
5 AMENDMENT DATED 12/16/03 TO THE COLLABORATION RESEARCH AGREEMENT dex1077.htm EX-10.77 22655
6 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 9210
7 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 9214
8 SECTION 906 CERTIFICATIONS OF CEO & CFO dex32.htm EX-32 8351
  Complete submission text file 0001193125-04-021528.txt   437849
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 04592981
SIC: 2834 Pharmaceutical Preparations